MoonLake Immunotherapeutics (MLTX) stock slips as Goldman Sachs downgrades the firm on concerns over the approvability of its lead asset
https://seekingalpha.com/news/4539562-moonlake-downgraded-sell-goldman-sachs
MoonLake Immunotherapeutics (MLTX) stock slips as Goldman Sachs downgrades the firm on concerns over the approvability of its lead asset
https://seekingalpha.com/news/4539562-moonlake-downgraded-sell-goldman-sachs
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.